Annexon Inc (ANNX NASDAQ) stock market data APIs
$4.5755
-0.05(-1.1%)
as of December 5, 2025
Try our APIs with
free plan!
Annexon Inc Financial Data Overview
Price chart is built with
Anychart
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases. The company's lead candidate is ANX005, an investigational full-length monoclonal antibody, which is in Phase 3 clinical trial for the treatment of patients with guillain-barré syndrome; completed Phase II clinical trial for treating Huntington's disease; and in Phase 2a clinical trial for the treatment of amyotrophic lateral sclerosis. The company is also developing ANX007, an antigen-binding fragment (Fab) that is in Phase 3 program for the treatment of patients with geographic atrophy; and ANX1502, a novel oral small molecule inhibitor, which is in Phase 1 clinical trials for autoimmune indications. In addition, it develops ANX009, a C1q-blocking Fab that is in Phase I clinical trial for treating patients with lupus nephritis. The company was incorporated in 2011 and is headquartered in Brisbane, California.
Prev. Close
4.5755
Open
4.5207
High
4.7502
Low
4.5196
52 wk Range
1.285-5.66
Market Cap
687 M
Shares Outstanding
149 M
EPS
-0.37
Beta
1.207
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Annexon Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Annexon Inc data using free add-ons & libraries
Get Annexon Inc Fundamental Data
Annexon Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -216 468 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-12
- EPS/Forecast: -0.3584
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Annexon Inc News
New
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Albemarle, Circle Internet, Cloudflare, Danaher, Inspire Medical, Six Flags, Workday and More
mezzotint / Shutterstock.com Quick Read December trading started off with a “risk off” session on Monday, with all major indices ending the day lower. After another year of double-digit gains fo...
Analyst Confidence Strong in Annexon (ANNX) Amid Vonaprument Advancement
Annexon, Inc. (NASDAQ:ANNX) is one of the 12 hot penny stocks to invest in right now.Analyst Confidence Strong in Annexon (ANNX) Amid Vonaprument Advancement On November 19, 2025, The Fly reported th...
Annexon stock rises after director purchases shares
[Stock market trading, financial data graph chart, data visualization, Business arrow graph chart] Rasi Bhadramani * Annexon (ANNX [https://seekingalpha.com/symbol/ANNX]) stock rose after the compa...
Annexon Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $86.25 Million
BRISBANE, Calif., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Annexon, Inc. (“Annexon”) (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform targeting neuroinflammation acr...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
